# Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/celiac-disease-developing-drugs-for-adjunctive-treatment-to-a-gluten-free-diet/4fbd41e3-3158-4644-a1f3-69e97587f939

> FDA guidance document: Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet. Issue date: April 15, 2022. Get complete insights and analysis.

---

## Details

- Title: Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-04-15
- Comment Close Date: 2022-06-14
- Last Changed: 2022-04-18
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-1238">FDA-2021-D-1238</a>

## Related Documents

- [Migraine:  Developing Drugs for Preventive Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-preventive-treatment/cd739d7c-f8ed-4a37-b16f-d6f3b9550a94)
- [Endogenous Cushing’s Syndrome: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/endogenous-cushings-syndrome-developing-drugs-for-treatment/c89a914f-8df3-4543-87dc-697dcbc10611)
- [Crohn’s Disease:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/crohns-disease-developing-drugs-for-treatment/10ab5c94-72ed-489d-b2cc-24cf6914fed5)